• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Stanford Aging and Ethnogeriatrics Research Center (SAGE Center)

Stanford Aging and Ethnogeriatrics Research Center (SAGE Center)

Ace Aging

  • LinkedIn
  • Twitter
  • Home
  • About Us
  • Awardees
  • Faculty
  • Research Methodology Podcasts
  • Research
  • Contact Us

SAGE awardees

Xin Zhou, Ph.D.

Postdoctoral Fellow
Department of Genetics

https://profiles.stanford.edu/214078

Dr. Xin Zhou received his Ph.D. on Genetics and Genome Sciences from University of Connecticut Health Center and The Jackson Laboratory for Genomic Medicine. He was trained under the Integrative Human Microbiome Project (https://www.hmpdacc.org/ihmp/ ) and have a particular focus on deciphering the complex interaction between human microbiome and the immune system. His work demonstrated an interaction between immune system and members from class Clostridia might improve the epithelium barrier integrity and therefore prevent the inflammation related to the onset and progression of insulin resistance.

Xin works at Department of Genetics at Stanford University exploring the systematic dynamics between human microbiome, transcriptome, immunome, lipidome, and metabolome during health and disease progression.

SAGE Project: Relating gastrointestinal dysbiosis in pulmonary arterial hypertension to rapid vascular aging

Pulmonary arterial hypertension (PAH) is characterized by increased blood pressure in the lungs and often with pathological thickening of arterial vessel wall. It was recently proposed the chronic inflammation-related vascular aging may contribute to the onset and development of PAH. This project will examine if altered gut microbiome-immune interactions is one of the common confounding factors between these two highly correlated phenotypes. Furthermore, we will identify specific microbial signatures in serum that could mechanistically explain the causational effect of dysbiosis towards low grade chronic inflammation—“inflammaging”.

Share this:

  • Twitter
  • Facebook
Previous Post: « Moderator, Mediators et al: Toward Understanding Heterogeneity
Next Post: Jiajun Wu, Ph.D. »

Ace Aging

Footer

Stanford Medicine

  • About
  • School Administration
  • Contact
  • Maps & Directions
  • Jobs

 

  • Basic Science Departments
  • Clinical Science Departments
  • Academic Programs
  • Diversity Programs

Healthcare

  • Find a physician
  • Clinical Trials
  • Patient Information
  • Contact

Related

  • Ethnogeriatrics
  • Salud (Spanish Health Site)
  • Project Respect
  •   Find People
  •   Visit Stanford
  •   Search Clinical Trials
  •   Give a Gift

Copyright © 2023 Stanford Medicine
Privacy Policy | Terms of Use

    Next-Generation Artificial Intelligence for Diagnosis: From Predicting Diagnostic Labels to "Wayfinding"

    Julia Adler-Milstein, PhD1; Jonathan H. Chen, MD, PhD; Gurpreet Dhaliwal, MD

    Improving the diagnostic process is a quality and safety priority.With the digitization of health records and rapid expansion of health data, the cognitive demand on the diagnostician has increased. The use of artificial intelligence (AI) to assist human cognition has the potential to reduce this demand and associated diagnostic errors. However, current AI tools have not realized this potential, due in part to the long-standing focus of these tools on predicting final diagnostic labels instead of helping clinicians navigate the dynamic refinement process of diagnosis. This Viewpoint highlights the importance of shifting the role of diagnostic AI from predicting labels to “wayfinding” (interpreting context and providing cues that guide the diagnostician).